FdaApplication
ANDA 210165
Identifiers
- fda_app_no: ANDA210165
Properties
| Property | Value |
|---|---|
| applicant_name | COREPHARMA LLC |
| application_type | ANDA |
| approval_date | 2021-01-22 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| PIOGLITAZONE HYDROCHLORIDE | PIOGLITAZONE HYDROCHLORIDE | EQ 30MG BASE | TABLET;ORAL |
| PIOGLITAZONE HYDROCHLORIDE | PIOGLITAZONE HYDROCHLORIDE | EQ 45MG BASE | TABLET;ORAL |
| PIOGLITAZONE HYDROCHLORIDE | PIOGLITAZONE HYDROCHLORIDE | EQ 15MG BASE | TABLET;ORAL |
3 products